FDA Brief

FDA warning letters

A warning letter is FDA's formal notice that a company broke the law, usually found during an inspection. The company has 15 working days to reply. Letters that go unanswered lead to seizures, import bans or court orders.

1,276 letters match. Newest first.

  1. Fei Fah Medical Manufacturing Pte. Ltd.

    FDA warned Fei Fah Medical Manufacturing over inadequate stability data, unvalidated test methods, and supplier testing failures for over-the-counter drugs.

    High risk
  2. Kobayashi Healthcare International, Inc.

    Kobayashi's Georgia plant released Zim's OTC pain drugs without microbial testing and lacked quality unit oversight, FDA says.

    High risk
  3. Mohawk Laboratories Division of NCH Corporation

    FDA warns Mohawk Laboratories that its hand sanitizer contained unacceptable acetaldehyde and acetal impurities.

    High risk
  4. Urban Electric Power

    Urban Electric Power hand sanitizers contained unacceptable acetaldehyde and acetal impurities and had CGMP violations.

    High risk
  5. Buzzagogo, LLC

    Buzzagogo's Allergy Bee Gone for Kids nasal swab is an unapproved new drug contaminated with Bacillus bacteria.

    High risk
  6. Larkin Community Hospital Institutional Review Board

    Larkin Community Hospital IRB cited for approving trials without required nonscientist member and incomplete records.

    Medium
  7. North American Custom Laboratories, LLC dba FarmaKeio Superior Custom Compounding

    FarmaKeio, a Texas compounding pharmacy, made sterile drugs under insanitary conditions that put patients at risk.

    High risk
  8. HIS Enterprise Inc dba Adam’s Secret USA, LLC

    FDA: Adam's Secret and Dr. Reade Slim Sense supplements sold online contain hidden prescription drugs tadalafil, sildenafil and lorcaserin.

    High risk
  9. Optum Infusion Services 308 LLC

    FDA warned Optum Infusion Services 308 LLC about insanitary conditions in sterile drug compounding after inspection found vermin and microbial contamination.

    High risk
  10. Medical Mikes, Inc.

    FDA and FTC warned Medical Mikes over unapproved CBD claims to prevent or treat COVID-19.

    High risk
  11. Purecraft LLC

    FDA and FTC warn Purecraft LLC over CBD products marketed with unapproved COVID-19 prevention and treatment claims.

    High risk
  12. Distributor RFR, LLC

    FDA: Distributor RFR's SANGTER male energy supplement contained undeclared sildenafil, making it an unapproved, misbranded new drug.

    High risk
  13. pharmahealthonline.com

    FDA warned pharmahealthonline.com for selling unapproved, misbranded opioid and benzodiazepine drugs to U.S. consumers online.

    High risk
  14. Auto-Chlor System LLC

    Auto-Chlor System LLC made hand sanitizer under poor manufacturing practices and sold it as an unapproved, misbranded new drug.

    High risk
  15. PharmaCanna

    FDA and FTC warn PharmaCanna over CBDefense 2000, a cannabinoid product claimed to prevent or treat COVID-19 without approval.

    High risk
  16. globalpharmacyplus.com

    FDA warned globalpharmacyplus.com in Canada for selling unapproved and misbranded prescription drugs to U.S. consumers online.

    High risk
  17. Superior Glove Works, Ltd.

    Canada's Superior Glove Works made hand sanitizers with ethanol containing unsafe acetaldehyde levels and skipped required testing, FDA says.

    High risk
  18. Green Pharmaceuticals Inc.

    FDA found Green Pharmaceuticals' SnoreStop NasoSpray contaminated with Providencia rettgeri and sold as an unapproved new drug.

    High risk
  19. MD Pharmaceutical Supply, LLC

    FDA warns MD Pharmaceutical Supply over API repackaging failures, including redistributing a returned lot and uncontrolled cross-contamination risks.

    High risk
  20. Adarsh Daswani, M.D.

    Clinical investigator Adarsh Daswani, M.D. failed to follow protocol dosing and oversight for an investigational drug study.

    High risk
  21. Nortec Quimica SA

    FDA warned Brazil's Nortec Quimica, an API maker, over deleted lab data and weak quality unit review of batches exported to the U.S.

    High risk
  22. DuPont Nutrition USA Inc.

    FDA found DuPont released Avicel excipient that failed conductivity limits, citing weak investigations and data integrity lapses.

    High risk
  23. Sagent Pharmaceuticals, Inc.

    FDA found SterRx, acquired by Sagent, made sterile drugs under conditions that risked contamination and lacked sterility assurance.

    High risk
  24. Centrient Pharmaceuticals India Private Limited

    Centrient Pharmaceuticals India's API plant drew FDA CGMP violations, including weak records and unproven beta-lactam contamination testing.

    High risk
  25. Thriftmaster Texas, LLC. d/b/a ThriftMaster Global Holdings, Inc. and TM Global Biosciences, LLC

    FDA warned Thriftmaster Texas over unapproved CBD drugs and CBD-added foods, citing disease and COVID-19 claims and an unsafe food additive.

    High risk
  26. Kari Gran Inc.

    Kari Gran Inc. released OTC SPF sunscreen drugs without adequate batch testing or stability data.

    High risk
  27. AG Hair Limited

    FDA warned AG Hair Limited over CGMP failures for hand sanitizer drugs, including inadequate investigations, microbiological controls, and component testing.

    High risk
  28. Glenmark Pharmaceuticals Limited

    FDA cited Glenmark's Goa plant for poor investigations, weak process validation, lab data controls, and incomplete batch records.

    High risk
  29. "David M. Lubeck, M.D./Arbor Centers for EyeCare

    FDA warned Dr. David Lubeck for running a combination-drug study without an IND and enrolling five subjects.

    High risk
  30. Shuzy Rock Inc.

    FDA warns Shuzy Rock Inc. of adulterated hand sanitizers made under insanitary conditions and found below labeled alcohol strength.

    High risk
  31. yourtramadol.com

    FDA warned yourtramadol.com for selling unapproved and misbranded tramadol opioid products to U.S. consumers online.

    High risk
  32. goodimmuno.com

    FDA warned goodimmuno.com for selling unapproved, misbranded tramadol and diazepam online without prescriptions.

    High risk
  33. The Anthos Group, Inc.

    Anthos Group refused FDA access to OTC drug records for VERTRA Hand Sanitizer, FDA says.

    Medium
  34. Omega & Delta Co., Inc.

    FDA says Omega & Delta's hand sanitizers were made under unsanitary conditions and with serious manufacturing quality failures.

    High risk
  35. Abraxis Bioscience LLC

    FDA warned Abraxis Bioscience about repeated contamination in media fills for sterile Abraxane at its Phoenix plant.

    High risk
  36. NatureLab Corp.

    FDA warned NatureLab Corp., a Carrollton, Texas dietary supplement maker, that its products are adulterated from CGMP violations and misbranded.

    Medium
  37. Alternative Health Distribution LLC d/b/a CannaAid

    FDA and FTC warned CannaAid over website claims that CBD/cannabinoid products prevent or treat COVID-19.

    High risk
  38. Latin Foods Market

    Latin Foods Market sold Artri King Reforzado con Ortiga y Omega 3, an unapproved drug with undeclared diclofenac and dexamethasone.

    High risk
  39. Walmart Inc.

    Walmart sold Artri King, a joint supplement containing undeclared diclofenac, making it an unapproved and misbranded new drug.

    High risk
  40. Amazon.com, Inc.

    Amazon sold three "Artri" and "Ortiga" arthritis supplements that lab tests found contained undisclosed diclofenac, an unapproved drug.

    High risk
  41. Nephron Pharmaceuticals Corporation dba Nephron Sterile Compounding Center, LLC

    FDA warned Nephron Sterile Compounding Center about insanitary sterile drug production and sterility assurance failures found in a 2022 inspection.

    High risk
  42. McConnell Labs Inc.

    McConnell Labs Inc. released hand sanitizers without raw material identity, finished product, or stability testing, FDA says.

    High risk
  43. Sovereign Pharmaceuticals, LLC

    FDA cited Sovereign Pharmaceuticals for manufacturing failures in bulk tablets, inadequate out-of-specification (OOS) investigations, quality-unit lapses, and an unapproved biological product.

    High risk
  44. Lupin Limited

    FDA warned Lupin Limited of current good manufacturing practice (CGMP) violations at its Tarapur API plant involving cleaning and genotoxic impurity controls.

    High risk
  45. Lakpura LLC

    FDA and Federal Trade Commission warned Lakpura LLC over ayurvedic products and teas with unapproved COVID-19 claims.

    High risk
  46. Unit Dose Services, LLC

    Unit Dose Services of Miami, Florida, listed Lisinopril with a carton label image showing a different drug, acetaminophen.

    Low
  47. Nephron SC Inc.

    Nephron SC's sterile drug manufacturing had unresolved cross-contamination and microbial contamination, making its drugs adulterated.

    High risk
  48. Advanced Cosmetic Research Laboratories Inc.

    FDA cited Advanced Cosmetic Research Laboratories for manufacturing-quality violations at its Chatsworth drug plant and an unapproved 5% lidocaine cream.

    High risk
  49. Beijing Xinggu Lvsan Technology Co., Ltd. Formerly known as Beijing Lvsan Technology Co., Ltd.

    FDA cites Beijing Xinggu Lvsan for manufacturing-rule failures and unapproved, misbranded hand sanitizers.

    High risk
  50. American Cleaning Solutions

    FDA warned American Cleaning Solutions after a 2022 inspection found hand sanitizer made with inadequate cleaning, unvalidated processes, and substituted ethanol.

    High risk